Improvement of ASCVD risk estimation with inclusion of three smoking variables. Read: ipccs.org/2022/03/04/imp… #CVD #smoking #risk #ASCVD

A meta-analyis on the worldwide prevalence of statin intolerance. Read: ipccs.org/2022/02/28/a-m… #statinintolerance #statins #LDLc #CVD

You need to measure iron deficiency in HF and treat it: ipccs.org/2022/03/07/iro… #irondeficiency #heartfailure #iron #CVD

Comparing two GLP-1RAs with regard to weight loss in overweight and obese adults. Read: ipccs.org/2022/02/16/com… #GLP1RA #overweight #obesity #weightloss

SGLT2i approved by EC for chronic HF regardless of ejection fraction. Read: ipccs.org/2022/03/09/sgl… #heartffailure #SGLT2inhibitor #FDAapproval

"During the pandemic, we have lost sight of long-term conditions that are the biggest contributors to worse outcomes", says prof. Hobbs. "We need to restart and catch up in CVD prevention ASAP." Watch: ipccs.org/2022/06/02/nee…

What are potential mechanisms of benefit of icosapent ethyl? Watch a video by Prof. Packard: ipccs.org/2022/06/20/wha… #icosapentethyl #fishoils #omega3FAs #CVD

In lower-income countries, association of prolonged sitting with mortality is more pronounced Read: ipccs.org/2022/07/11/in-… #sitting #CVD

Two DOACs compared for recurrent VTE and bleeding in patients with VTE Read: ipccs.org/2022/07/06/two… #DOAC #VTE #thrombosis #bleeding

Triglyceride-rich lipoproteins as residual CV risk in patients on statins. Watch: ipccs.org/2022/05/08/tri… #CVD #lipids #triglycerides #statines

Fitting in bempedoic acid in the arsenal of lipid-lowering therapies. Watch: ipccs.org/2023/03/30/fit… #bempedoicacid #LDLc #lipids #CLEAROutcomes #CVD

Association between lifelong endurance exercise and higher coronary plaque burden Read: ipccs.org/2023/03/14/ass… #exercise #plaques #CVD

Association of self-reported keto diet with LDL-c and apoB levels and CV events. Read: ipccs.org/2023/03/14/ass… #ketodiet #LDLc #apoB #diet #CVD

Results for oral PCSK9 inhibitor promising to proceed to phase 3 trials. Watch: ipccs.org/2023/03/09/res… #oralPCSK9i #PCSK9inhibitor #LDLc #CVD

The AHA has published a scientific statement on the cardiopulmonary impact of e-cigarettes and vaping products. Read more: ipccs.org/2023/08/21/sci… The use of e-cigarettes and vaping products is increasing in the US. Do you see an increased usage of these products in Europe?#poll

Global association of the PURE healthy diet score with health outcomes Read: ipccs.org/2023/09/25/glo… #diet #CVD #mortality #dietscore #PUREhealthyscore

Consistent benefit of SGLT2 inhibitors on CV outcomes across various patient populations Read: ipccs.org/2023/09/21/con… #SGLT2 #CVD #Cardiotwitter #T2D #HF #CKD #diabetes #heartfailure #comorbidity

Daily step counts to reduce mortality and CVD risks for healthy individuals A meta-analysis showed that walking ~8800 steps/day lowered mortality risk by 60%, while a daily step count of ~7200 reduced CVD risk by 51%. Read: ipccs.org/2023/10/02/dai… #CardioTwitter #CVD #steps

Elderly people also benefit from lipid-lowering therapy for primary prevention Read more: ipccs.org/2023/11/29/eld… #CardioTwitter #lipidlowering #lipids #primaryprevention #eldery #LDLc #CVD #riskreduction

💬 97% would recommend Advancements in Obesity Management to a colleague ⭐ 98.2% rated content very good or excellent 🔄 96.6% said it could change clinical practice Advancements in Obesity Management 2025 brought together an incredible global faculty: Harold Bays, Naveed